$500M–$1B

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm. The firm focuses on helping growing health care companies achieve their full potential while improving global health care. They manage capital in both private and public equity funds, investing across all sectors of the health care industry, including biopharmaceutical services, health care services, and medical devices. Great Point Partners is known for its proactive and proprietary approach to sourcing investments and has provided growth equity, recapitalization, and management buyout financing to more than 200 health care companies.

Black Diamond Ventures (BDV) is a transformational venture capital firm with over two decades of experience in hybrid investing. Founded by Chris Lucas, BDV focuses on multi-stage investments in biotech, deep tech, and med tech sectors, supporting visionary founders with strategic and operational guidance. The firm is committed to building relationships among investors and their investments, helping founders reach the next level through a network of partners and strategic opportunities.

Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.

Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on investing in businesses that enable better care at lower cost, with a strong presence in Europe and North America. Gilde Healthcare is headquartered in Utrecht, the Netherlands, with additional offices in Frankfurt, Germany, and Boston, USA.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

NewSpring Capital is a private equity firm that partners with lower-middle market companies to create measurable value for business owners and Limited Partners. With over 25 years of experience, NewSpring focuses on fostering deep and enduring relationships, aligning goals and values with entrepreneurs, investors, and employees in pursuit of excellence. The firm manages over $3.5 billion across five distinct strategies, including growth equity, healthcare, mezzanine debt, holdings, and franchise investments. NewSpring is committed to accelerating growth and success for its portfolio companies through tailored capital solutions and strategic support.

RiverVest Venture Partners is a leading venture capital firm focused on building life science companies to address significant unmet medical needs. The firm is dedicated to improving the lives of patients, supporting entrepreneurs, and earning the trust of investors through science, strategy, and innovation. With a strong track record of successful investments and exits, RiverVest leverages its expertise to develop biopharma and medical device products that meet high, unmet medical needs, aiming for commercialization or IPO within three to five years of investment.

Omega Funds is a venture capital firm dedicated to investing in the future of medicine. The firm focuses on supporting exceptional founders and entrepreneurs in developing impactful products and platforms across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Funds aims to bring science to patients by investing in innovative solutions that address significant medical needs.

SeedFolio is a venture capital firm based in San Diego, focusing on early-stage investments in companies developing novel technologies to conquer disease and clean the planet. The firm aims to generate significant benefits for patients and customers while achieving substantial profits for the company and its investors. SeedFolio employs a rigorous and systematic process to source and select companies with high reward/risk ratios.

Tech Council Ventures is a venture capital firm that invests in early-stage, rapid-growth technology companies in the Mid-Atlantic region. The firm focuses on sectors such as life sciences, digital health, biotech, medical devices, and therapeutics. With a strong network and expertise, Tech Council Ventures aims to support entrepreneurs by providing capital, strategic guidance, and access to a wide range of resources to help them succeed in large and growing markets.

Sofinnova is a leading healthcare investment firm with a focus on life sciences, particularly therapeutic drugs. Founded in 1976, the firm has a strong track record of investing in transformative therapies, guiding companies from drug development through regulatory processes to IPOs. With approximately $3.3 billion in assets under management, Sofinnova partners with entrepreneurs to improve patient lives through science, leveraging deep industry knowledge and extensive experience in both private and public equity markets.